Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab Plus Bevacizumab”

168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 168 results

Testing effectiveness (Phase 2)UnknownNCT03616691
What this trial is testing

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Samsung Medical Center 46
Testing effectiveness (Phase 2)UnknownNCT03647956
What this trial is testing

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVEGFR Activating Mutation
The University of Hong Kong 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03526432
What this trial is testing

Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 110
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Testing effectiveness (Phase 2)Study completedNCT02873195
What this trial is testing

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colorectal CarcinomaRefractory Colorectal Carcinoma+3 more
Academic and Community Cancer Research United 133
Early research (Phase 1)WithdrawnNCT05510427
What this trial is testing

Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification

Who this might be right for
CholangiocarcinomaLiver Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT04194203
What this trial is testing

Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 305
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Testing effectiveness (Phase 2)Study completedNCT05359861
What this trial is testing

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Large-scale testing (Phase 3)Study completedNCT03434379
What this trial is testing

Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 558
Testing effectiveness (Phase 2)UnknownNCT04659382
What this trial is testing

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerpMMRMSS+2 more
Federation Francophone de Cancerologie Digestive 52
Testing effectiveness (Phase 2)Study completedNCT04426825
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 23
Large-scale testing (Phase 3)Study completedNCT05665348
What this trial is testing

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaMetastatic CancerMetastatic Tumor
Federation Francophone de Cancerologie Digestive 229
Testing effectiveness (Phase 2)Looking for participantsNCT06294548
What this trial is testing

Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Who this might be right for
Hepatocellular Carcinoma
University of Alabama at Birmingham 45
Early research (Phase 1)Study completedNCT03063762
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)UnknownNCT05760599
What this trial is testing

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Who this might be right for
Hepatocellular Carcinoma
Shi Ming 30
Early research (Phase 1)Looking for participantsNCT05488522
What this trial is testing

SBRT With Atezo/Bev for HCC

Who this might be right for
Hepatocellular Carcinoma
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT06789757
What this trial is testing

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Inova Health Care Services 19
Early research (Phase 1)Active Not RecruitingNCT05546879
What this trial is testing

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 43
Next Page